Pipeline

OUR PRODUCTS
Our candidates, close to start clinical development, meet criteria being highly desirable features for CNS damage treatment
- Our products are small peptides derived from the most conserved sequence of the thrombospondin repeat (TSRs) of the SCO-spondin, a naturally secreted protein with potent activity during neurogenesis
- TSRs are active domains involved in various context-dependent pathways and contributing in angiogenesis and axon guidance
-
Our drug candidates have multifunctional activities on neural cells, encompassing:
- Neuroprotection with strong anti-oxidative properties & anti-apoptotic activities
- Regenerative & remodeling properties including neurite outgrowth to restore lost function
- Cellular plasticity mechanisms